Felicia Ikolo: Could Earlier Oxygen Therapy Change the Course of Sickle Cell Crisis?
Felicia Ikolo, Associate Professor at St. George’s University, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Biomedicines MDPI, adding:
“Can early oxygen intervention help break the hypoxia-driven vicious cycle in a sickle cell vaso-occlusive crisis?
Delighted to share our new structured narrative review published in Biomedicines MDPI!
In this paper, our interdisciplinary team at St. George’s University explores the molecular rationale behind early oxygen administration, highlighting the urgent need for rigorous clinical studies and practical solutions that could benefit resource-limited health systems.
Proud to have collaborated with an incredible group of student and faculty co-authors on this global health initiative!”
Title: Oxygen Timing as Therapy: Molecular Rationale and Clinical Imperative for Early Oxygen Administration in the Sickle Cell Disease Vaso-Occlusive Crisis—A Structured Narrative Review with Implications for Resource-Constrained Health Systems
Authors: Kanwarjot Singh, Dervens Michaud, Tal Parness, Odinaka Mgbeke, Henry Okodaso, Kwami Jones, Bawo Teddy Ikolo, Shellon Thomas, Felicia Ikolo

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian